- Home
- Products
- Anti-Ab ADCs
- IgG Fc
- anti-MIgG(Fc)Fab-C-MMAE ADC
anti-MIgG(Fc)Fab-C-MMAE ADC (CAT#: ADC-AA-029)
This ADC product is comprised of a Fab fragment of an anti-mouse IgG Fc specific polyclonal antibody conjugated via a cleavable linker to MMAE. The antibody portion is a Fab fragment of a secondary antibody and the drug portion, MMAE, is a cytotoxic small molecule which binds to tubulins, interrupts microtubule dynamics, and induces cell death. This product displays no obvious toxicity without a primary antibody and can be a quite efficient and economical alternative to pre-screening mouse monoclonal antibodies as ADC candidates.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- IgG Fc
- Overview
- The fragment crystallizable region (Fc region) is composed of the constant region of the two heavy chains that form the IgG molecule. The Fc region of IgG bears a highly conserved N-glycosylation site. Glycosylation of the Fc fragment is essential for Fc receptor-mediated activity. Fc binds to various cell receptors and complement proteins thus mediating different physiological effects of antibodies, such as opsonization, antibody dependent cellular cytotoxicity (ADCC), degranulation of mast cells, basophils, eosinophils and other processes.
- Overview
- Fab fragment of anti-mouse IgG Fc specific polyclonal antibody
- Species Reactivity
- Mouse
- Name
- Cleavable linkers
- Description
- Cleavable linkers rely on the physiological stimuli, which mainly include chemically cleavable linkers and enzymatically cleavable linkers. Chemically cleavable linkers including acid-labile linkers and disulfide linkers. For acid-labile linkers, intracellular release of payloads relies on the different pH between endosomes/lysosomes and blood. The release of disulfide-linked drugs is controlled by the factors in intracellular environment. Enzymatically cleavable linkers, peptide linkers and β-glucuronide linkers, are sensitive to enzymes located in cytoplasm.
- Name
- MMAE (Monomethyl auristatin E)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Protein A-PBD ADC (CAT#: WJY-0423-LS107)
- Protein A-MMAF ADC (CAT#: ADC-AA-053)
- anti-HIgG(Fc)Fab-C-MMAF ADC (CAT#: ADC-AA-010)
- anti-Rat IgG(HL)Fab-N-MMAF ADC (CAT#: ADC-AA-046)
- anti-RIgG(HL)-N-MMAF ADC (CAT#: ADC-AA-034)
- anti-HIgG(Fc)-C-DMDM ADC (CAT#: ADC-AA-006)
- anti-MIgG(Fc)-C-PNU ADC (CAT#: ADC-AA-025)
- Anti-HIgG(Fab)-N-MMAF ADC (CAT#: ADC-AA-063)
- Protein G-MCC-DM1 ADC (CAT#: ADC-AA-050)
- Anti-MIgG(Fc)-C-PBD ADC (CAT#: ADC-AA-058)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-AA-029. Click the button above to contact us or submit your feedback about this product.
Customer Reviews
FAQ

Excellent
Efficient Screening Tool We used the anti-MIgG(Fc)Fab-C-MMAE ADC from Creative Biolabs for pre-screening our mouse monoclonal antibodies. Its selective cytotoxicity significantly streamlined our screening process, reducing both time and resource expenditure.

Excellent
Targeted Cytotoxicity This ADC product delivered impressive results with minimal off-target effects. The MMAE component provided potent cytotoxic activity, proving crucial in our antibody candidate validation.

Excellent
Cost-Effective The anti-MIgG(Fc)Fab-C-MMAE ADC from Creative Biolabs has been a game-changer for us. It's an economical alternative for ADC screening, saving us from costly full antibody conjugations in early experiments.

Excellent
Specificity and Efficacy Impressed by the high specificity and efficacy of the Fab fragment in targeting mouse IgG Fc. The MMAE linker activation in the presence of a primary antibody worked flawlessly, confirming its utility in our labs.

Excellent
Research Enhancement The anti-MIgG(Fc)Fab-C-MMAE ADC has enhanced the efficiency and accuracy of our research projects. It effectively induces cell death only in the presence of target antibodies, ensuring reliable results.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-AA-048 | Protein G-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-AA-026 | anti-MIgG(Fc)-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-AA-021 | anti-MIgG(Fc)-C-MMAE ADC | Cleavable linkers | MMAE (Monomethyl auristatin E) |
ADC-AA-049 | Protein G-MMAF ADC | MMAF (Monomethyl auristatin F) | |
ADC-AA-031 | anti-MIgG(Fc)Fab-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
CAT# | Product Name | Linker | Payload |
ADC-AA-002 | anti-HIgG(Fc)-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
ADC-AA-028 | anti-MIgG(Fc)Fab-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
WJY-0423-LS107 | Protein A-PBD ADC | Cleavable linkers | PBD (pyrrolobenzodiazepine) |
ADC-AA-066 | Anti-Rat IgG(H+L)-C-PBD ADC | Cleavable linkers | PBD (pyrrolobenzodiazepine) |
ADC-AA-020 | anti-MIgG(Fc)-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
CAT# | Product Name | Linker | Payload |
ADC-W-499 | Anti-SLC34A2 (Lifastuzumab)-VC-MMAE ADC | mc-VC-PABC | MMAE (Monomethyl auristatin E) |
ADC-W-565 | Anti-EDNRB-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-AA-011 | anti-HIgG(Fc)Fab-C-MMAE ADC | Cleavable linkers | MMAE (Monomethyl auristatin E) |
ADC-W-536 | Anti-EDNRB (endothelin B)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-W-564 | Anti-MUC16-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.